Hydrogen peroxide-mediated nuclear factor κB activation in both liver and tumor cells during initial stages of hepatic metastasis

Cancer Science

Volumn 99, Issue 8, 2008, Pages 1546-1552

  Kobayashi, Yuki ^a   Nishikawa, Makiya ^a   Hyoudou, Kenji ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; FIREFLY LUCIFERASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLASMID DNA; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CANCER STAGING; CONTROLLED STUDY; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HYDRODYNAMICS BASED TRANSFECTION; IN VITRO GENE TRANSFER; INOCULATION; LIVER CELL; LIVER CIRCULATION; LIVER METASTASIS; METASTASIS INHIBITION; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR CELL;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HYDROGEN PEROXIDE; LIVER NEOPLASMS; LUCIFERASES; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; OXIDANTS;

EID: 49749145899     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00856.x     Document Type: Article

References (43)

1. Hayden MS, Ghosh S. Signal to NF-kappaB. Genes Dev 2004; 18: 2195-224.
2. Inoue J, Gohda J, Akiyama T, Semba K. NF-kappaB activation in development and progression of cancer. Cancer Sci 2007; 98: 268-74.
3. Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: Balancing life and death - a new approach to cancer therapy. J Clin Invest 2005; 115: 2625-32.
4. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431-6.
5. Park BK, Zhang H, Zeng Q et al. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 2007; 13: 62-9.
6. Bassères DS, Baldwin AS. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006; 25: 6817-30.
7. Scaife CL, Kuang J, Wills JC et al. Nuclear factor kappaB inhibitors induce adhesion-dependent colon cancer apoptosis: Implications for metastasis. Cancer Res 2002; 62: 6870-8.
8. Liu YX, Cao WS, Irani K, Li XJ. Establishment of a T-Ag and NF-kappaB binding elements gene co-transfected stable HUVECs cell line. J Cell Biochem 2003; 89: 1285-90.
9. Carlsen H, Moskaug JO, Fromm SH, Blomahoff R. In vivo imaging of NF-kappa B activity. J Immunol 2002; 168: 1441-6.
10. Maggi A, Ciana P. Reporter mice and drug discovery and development. Nat Rev Drug Discov 2005; 4: 249-55.
11. Kobayashi N, Kuramoto T, Yamaoka K, Hashida M, Takakura Y. Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. J Pharmacol Exp Ther 2001; 297: 853-60.
12. Kobayashi N, Kuramoto T, Chen S, Watanabe Y, Takakura Y. Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models. Mol Ther 2002; 6: 737-44.
13. Kobayashi N, Nishikawa M, Hirata K, Takakura Y. Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: Implication of a nonspecific process in efficient intracellular gene delivery. J Gene Med 2004; 6: 584-92.
14. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258-66.
15. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735-7.
16. Hyoudou K, Nishikawa M, Kobayashi Y, Kuramoto Y, Yamashita F, Hashida M. Analysis of in vivo nuclear factor-kappaB activation during liver inflammation in mice: Prevention by catalase delivery. Mol Pharmacol 2007; 71: 446-53.
17. Yabe Y, Nishikawa M, Tamada A, Takakura Y, Hashida M. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives. J Pharmacol Exp Ther 1999; 289: 1176-84.
18. Térouanne B, Tahiri B, Georget V et al. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. Mol Cell Endocrinol 2000; 160: 39-49.
19. Hyoudou K, Nishikawa M, Umeyama Y, Kobayashi Y, Yamashita F, Hashida M. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: Quantitative analysis with firefly luciferase-expressing melanoma cells. Clin Cancer Res 2004; 10: 7685-91.
20. Jahnke C, Mehrabi A, Golling M et al. Evaluation of microperfusion disturbances in the transplanted liver after Kupffer cell destruction using GdCl3: An experimental porcine study. Transplant Proc 2006; 38: 1588-95.
21. Aggarwal BB, Shishodia S, Takada Y et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 2005; 11: 7490-8.
22. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 2001; 107: 241-6.
23. Nakanishi C, Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 2005; 5: 297-309.
24. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NF-kappaB signaling module: Temporal control and selective gene activation. Science 2002; 298: 1241-5.
25. Nelson DE, Ihekwaba AE, Elliott M et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 2004; 306: 704-8.
26. Zhang L, Hellstrom KE, Chen L. Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin Exp Metastasis 1994; 12: 87-92.
27. El Hilali N, Rubio N, Martinez-Villacampa M, Blanco J. Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases. Lab Invest 2002; 82: 1563-71.
28. Bouvet M, Tsuji K, Yang M, Jiang P, Moossa AR, Hoffman RM. In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res 2006; 66: 11.293-7.
29. Hyoudou K, Nishikawa M, Kobayashi Y, Umeyama Y, Yamashita F, Hashida M. Pegylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic Biol Med 2006; 41: 1449-58.
30. Hyoudou K, Nishikawa M, Kobayashi Y, Kuramoto Y, Yamashita F, Hashida M. Inhibition of adhesion and proliferation of peritoneally disseminated tumor cells by pegylated catalase. Clin Exp Metastasis 2006; 23: 269-78.
31. Hyoudou K, Nishikawa M, Kobayashi Y et al. Inhibition of peritoneal dissemination of tumor cells by cationized catalase in mice. J Control Release 2007; 119: 121-7.
32. Kuramoto Y, Nishikawa M, Hyoudou K, Yamashita F, Hashida M. Inhibition of peritoneal dissemination of tumor cells by single dosing of phosphodiester CpG oligonucleotide/cationic liposome complex. J Control Release 2006; 115: 226-33.
33. Mook OR, Van Marle J, Vreeling-Sindelárová H, Jonges R, Frederiks WM, Van Noorden CJ. Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 2003; 38: 295-304.
34. Nishikawa M, Tamada A, Hyoudou K et al. Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin Exp Metastasis 2004; 21: 213-21.
35. Khatib AM, Auguste P, Fallavollita L et al. Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol 2005; 167: 749-59.
36. Auguste P, Fallavollita L, Wang N, Burnier J, Bikfalvi A, Brodt P. The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol 2007; 170: 1781-92.
37. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 1994; 7: 959-62.
38. Balkwill F, Coussens LM. Cancer: An inflammatory link. Nature 2004; 431: 405-6.
39. Okada F, Kobayashi M, Tanaka H et al. The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells. Am J Pathol 2006; 169: 294-302.
40. Timmers M, Vekemans K, Vermijlen D et al. Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 2004; 112: 793-802.
41. de Oliveira-Marques V, Cyrne L, Marinho HS, Antunes F. A quantitative study of NF-kappaB activation by H2O2: Relevance in inflammation and synergy with TNF-alpha. J Immunol 2007; 178: 3893-902.
42. Nishikawa M, Tamada A, Kumai H, Yamashita F, Hashida M. Inhibition of experimental pulmonary metastasis by controlling biodistribution of catalase in mice. Int J Cancer 2002; 99: 474-9.
43. Nishikawa M, Hyoudou K, Kobayashi Y, Umeyama Y, Takakura Y, Hashida M. Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes. J Control Release 2005; 109: 101-7.